A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework.

A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework.

A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework. 400 518 Curaleaf Australia
Medical Cannabis, CBD Wellness Products and Public Awareness of Evolving Regulations in the United Kingdom
Cannabidiol’s Cytotoxicity in Pancreatic Cancer is Induced via an Upregulation of Ceramide Synthase 1 and ER Stress

©2026 CURALEAF AUSTRALIA

Privacy Policy

LEVEL 5, 126 PHILLIP STREET, SYDNEY, 2000, NSW

curaleaf.aus@curaleafint.com

For healthcare professionals only. Curaleaf Australia products are prescription-only and intended for healthcare professionals and stakeholders only. This website does not promote the use or supply of medicinal cannabis to the public. Not for public promotion or recreational use.

Back to top